These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
504 related items for PubMed ID: 9469424
1. Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood. Deo YM, Sundarapandiyan K, Keler T, Wallace PK, Graziano RF. J Immunol; 1998 Feb 15; 160(4):1677-86. PubMed ID: 9469424 [Abstract] [Full Text] [Related]
2. A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells. Guettinger Y, Barbin K, Peipp M, Bruenke J, Dechant M, Horner H, Thierschmidt D, Valerius T, Repp R, Fey GH, Stockmeyer B. J Immunol; 2010 Feb 01; 184(3):1210-7. PubMed ID: 20042573 [Abstract] [Full Text] [Related]
3. Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cells. Keler T, Graziano RF, Mandal A, Wallace PK, Fisher J, Guyre PM, Fanger MW, Deo YM. Cancer Res; 1997 Sep 15; 57(18):4008-14. PubMed ID: 9307286 [Abstract] [Full Text] [Related]
4. Development of a trispecific antibody conjugate that directs two distinct tumor-associated antigens to CD64 on myeloid effector cells. Somasundaram C, Sundarapandiyan K, Keler T, Deo YM, Graziano RF. Hum Antibodies; 1999 Sep 15; 9(1):47-54. PubMed ID: 10331185 [Abstract] [Full Text] [Related]
5. Differential effect of cytokine treatment on Fc alpha receptor I- and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages. Keler T, Wallace PK, Vitale LA, Russoniello C, Sundarapandiyan K, Graziano RF, Deo YM. J Immunol; 2000 Jun 01; 164(11):5746-52. PubMed ID: 10820252 [Abstract] [Full Text] [Related]
6. Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer. Stockmeyer B, Valerius T, Repp R, Heijnen IA, Bühring HJ, Deo YM, Kalden JR, Gramatzki M, van de Winkel JG. Cancer Res; 1997 Feb 15; 57(4):696-701. PubMed ID: 9044847 [Abstract] [Full Text] [Related]
7. Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level. Connor RI, Shen L, Fanger MW. J Immunol; 1990 Sep 01; 145(5):1483-9. PubMed ID: 1696598 [Abstract] [Full Text] [Related]
8. Fc alpha receptors mediate release of tumour necrosis factor-alpha and interleukin-6 by human monocytes following receptor aggregation. Patry C, Herbelin A, Lehuen A, Bach JF, Monteiro RC. Immunology; 1995 Sep 01; 86(1):1-5. PubMed ID: 7590867 [Abstract] [Full Text] [Related]
9. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. Graziano RF, Fanger MW. J Immunol; 1987 Nov 15; 139(10):3536-41. PubMed ID: 2960735 [Abstract] [Full Text] [Related]
10. Functions of the various IgG Fc receptors in mediating killing of Toxoplasma gondii. Erbe DV, Pfefferkorn ER, Fanger MW. J Immunol; 1991 May 01; 146(9):3145-51. PubMed ID: 1826707 [Abstract] [Full Text] [Related]
11. Characterization of a novel bispecific antibody that mediates Fcgamma receptor type I-dependent killing of tumor-associated glycoprotein-72-expressing tumor cells. Russoniello C, Somasundaram C, Schlom J, Deo YM, Keler T. Clin Cancer Res; 1998 Sep 01; 4(9):2237-43. PubMed ID: 9748144 [Abstract] [Full Text] [Related]
12. Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4. van der Steen L, Tuk CW, Bakema JE, Kooij G, Reijerkerk A, Vidarsson G, Bouma G, Kraal G, de Vries HE, Beelen RH, van Egmond M. Gastroenterology; 2009 Dec 01; 137(6):2018-29.e1-3. PubMed ID: 19555692 [Abstract] [Full Text] [Related]
13. Human monocyte-mediated cytotoxicity: the use of Ig-bearing hybridomas as target cells to detect trigger molecules on the monocyte cell surface. Graziano RF, Fanger MW. J Immunol; 1987 Feb 01; 138(3):945-50. PubMed ID: 2949010 [Abstract] [Full Text] [Related]
14. Human monocyte-mediated cytotoxicity towards erythrocytes induced by hybrid mouse monoclonal antibodies: effect of antibody binding valency on IgG-Fc gamma R interaction. Koolwijk P, Van de Winkel JG, Otten I, Bast BJ. Immunology; 1992 Feb 01; 75(2):336-42. PubMed ID: 1532380 [Abstract] [Full Text] [Related]
15. Induction of intracellular Ca2+ mobilization and cytotoxicity by hybrid mouse monoclonal antibodies. Fc gamma RII regulation of Fc gamma RI-triggered functions or signaling? Koolwijk P, Van de Winkel JG, Pfefferkorn LC, Jacobs CW, Otten I, Spierenburg GT, Bast BJ. J Immunol; 1991 Jul 15; 147(2):595-602. PubMed ID: 1830069 [Abstract] [Full Text] [Related]
16. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64). Chen J, Zhou JH, Ball ED. Clin Cancer Res; 1995 Nov 15; 1(11):1319-25. PubMed ID: 9815927 [Abstract] [Full Text] [Related]
17. Targeting FcαRI on polymorphonuclear cells induces tumor cell killing through autophagy. Bakema JE, Ganzevles SH, Fluitsma DM, Schilham MW, Beelen RH, Valerius T, Lohse S, Glennie MJ, Medema JP, van Egmond M. J Immunol; 2011 Jul 15; 187(2):726-32. PubMed ID: 21653835 [Abstract] [Full Text] [Related]
18. Generation of HER-2/neu-specific cytotoxic neutrophils in vivo: efficient arming of neutrophils by combined administration of granulocyte colony-stimulating factor and Fcgamma receptor I bispecific antibodies. Heijnen IA, Rijks LJ, Schiel A, Stockmeyer B, van Ojik HH, Dechant M, Valerius T, Keler T, Tutt AL, Glennie MJ, van Royen EA, Capel PJ, van de Winkel JG. J Immunol; 1997 Dec 01; 159(11):5629-39. PubMed ID: 9548506 [Abstract] [Full Text] [Related]
19. Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function. Guyre PM, Graziano RF, Vance BA, Morganelli PM, Fanger MW. J Immunol; 1989 Sep 01; 143(5):1650-5. PubMed ID: 2474608 [Abstract] [Full Text] [Related]